These results suggest that dysadherin expression might be an excellent indicator of the patients with advanced colorectal carcinoma and the combined immunohistochemical analysis of dysadherin and E-cadherin expression could give us further prognostic information. The gene discussed is FXYD5; the disease is colorectal carcinoma.